{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:16:33Z","timestamp":1778886993967,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T00:00:00Z","timestamp":1719964800000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006449","name":"Center for Advanced Vehicular Systems, Mississippi State University","doi-asserted-by":"publisher","award":["NCT04968509"],"award-info":[{"award-number":["NCT04968509"]}],"id":[{"id":"10.13039\/100006449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006449","name":"Center for Advanced Vehicular Systems, Mississippi State University","doi-asserted-by":"publisher","award":["P < 0.001"],"award-info":[{"award-number":["P < 0.001"]}],"id":[{"id":"10.13039\/100006449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006449","name":"Center for Advanced Vehicular Systems, Mississippi State University","doi-asserted-by":"publisher","award":["1.316\\u20132.062"],"award-info":[{"award-number":["1.316\\u20132.062"]}],"id":[{"id":"10.13039\/100006449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006449","name":"Center for Advanced Vehicular Systems, Mississippi State University","doi-asserted-by":"publisher","award":["1.647"],"award-info":[{"award-number":["1.647"]}],"id":[{"id":"10.13039\/100006449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006449","name":"Center for Advanced Vehicular Systems, Mississippi State University","doi-asserted-by":"publisher","award":["11,12"],"award-info":[{"award-number":["11,12"]}],"id":[{"id":"10.13039\/100006449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006449","name":"Center for Advanced Vehicular Systems, Mississippi State University","doi-asserted-by":"publisher","award":["NCT03051360"],"award-info":[{"award-number":["NCT03051360"]}],"id":[{"id":"10.13039\/100006449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34089","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T20:08:23Z","timestamp":1720037303000},"page":"e34089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Genetic proxy of lipid-lowering drugs and calcific aortic valve stenosis: A Mendelian randomization study"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8326-2043","authenticated-orcid":false,"given":"Yucheng","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanchuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8873-732X","authenticated-orcid":false,"given":"Ziheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.heliyon.2024.e34089_bib1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2013.05.015","article-title":"Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study","volume":"62","author":"Osnabrugge","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34089_bib2","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1161\/ATVBAHA.114.302523","article-title":"Calcific aortic valve disease: a consensus summary from the Alliance of investigators on calcific aortic valve disease","volume":"34","author":"Yutzey","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34089_bib3","doi-asserted-by":"crossref","first-page":"12710","DOI":"10.18632\/aging.202942","article-title":"Changing epidemiology of calcific aortic valve disease: 30-year trends of incidence, prevalence, and deaths across 204 countries and territories","volume":"13","author":"Yi","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34089_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/ATVBAHA.119.313067","article-title":"Aortic valve stenosis: from basic mechanisms to novel therapeutic targets","volume":"40","author":"Goody","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34089_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis--from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34089_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCOUTCOMES.112.966002","article-title":"Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis","volume":"5","author":"Clark","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34089_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1161\/CIRCULATIONAHA.118.035236","article-title":"Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk","volume":"139","author":"Baron","year":"2019","journal-title":"Circulation"},{"issue":"47","key":"10.1016\/j.heliyon.2024.e34089_bib8","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.heliyon.2024.e34089_bib9","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/eurheartj\/ehac050","article-title":"Calcific aortic valve disease: novel insights into nitric oxide signalling","volume":"43","author":"Kraler","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.heliyon.2024.e34089_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/851945","article-title":"Innate and adaptive immunity in calcific aortic valve disease","volume":"2015","author":"Mathieu","year":"2015","journal-title":"J Immunol Res"},{"issue":"23","key":"10.1016\/j.heliyon.2024.e34089_bib11","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34089_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e34089_bib13","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2024.e34089_bib14","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"issue":"23","key":"10.1016\/j.heliyon.2024.e34089_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11237249","article-title":"Comparison of current international guidelines for the management of dyslipidemia","volume":"11","author":"Aygun","year":"2022","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34089_bib16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3904\/kjim.2019.188","article-title":"2018 Guidelines for the management of dyslipidemia","volume":"34","author":"Rhee","year":"2019","journal-title":"Korean J Intern Med"},{"issue":"D1","key":"10.1016\/j.heliyon.2024.e34089_bib17","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34089_bib18","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"Vosa","year":"2021","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34089_bib19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat. Genet."},{"issue":"7944","key":"10.1016\/j.heliyon.2024.e34089_bib20","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2024.e34089_bib21","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34089_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat. Genet."},{"issue":"7414","key":"10.1016\/j.heliyon.2024.e34089_bib23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34089_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"Burgess","year":"2011","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34089_bib25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2021.0005","article-title":"Association of antihypertensive drug target genes with psychiatric disorders: a mendelian randomization study","volume":"78","author":"Chauquet","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.heliyon.2024.e34089_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1260780","article-title":"Genome-wide Mendelian randomization identifies putatively causal gut microbiota for multiple peptic ulcer diseases","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34089_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10654-017-0276-5","article-title":"Erratum to: interpreting findings from Mendelian randomization using the MR-Egger method","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34089_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34089_bib29","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCRESAHA.118.311227","article-title":"PCSK9: from basic science discoveries to clinical trials","volume":"122","author":"Shapiro","year":"2018","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34089_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1177\/0300060516648030","article-title":"Proprotein convertase subtilisin\/kexin type 9 levels and aortic valve calcification: a prospective, cross sectional study","volume":"44","author":"Wang","year":"2016","journal-title":"J. Int. Med. Res."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34089_bib31","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","article-title":"Genetic and in vitro inhibition of PCSK9 and calcific aortic valve stenosis","volume":"5","author":"Perrot","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"24","key":"10.1016\/j.heliyon.2024.e34089_bib32","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1016\/j.jacc.2018.09.063","article-title":"PCSK9 involvement in aortic valve calcification","volume":"72","author":"Poggio","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.heliyon.2024.e34089_bib33","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2016-1206","article-title":"PCSK9 R46L loss-of-function mutation reduces lipoprotein(a), LDL cholesterol, and risk of aortic valve stenosis","volume":"101","author":"Langsted","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e34089_bib34","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34089_bib35","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacbts.2020.06.004","article-title":"PCSK9 and calcific aortic valve stenosis: moving beyond lipids","volume":"5","author":"Leopold","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34089_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An exploratory analysis of proprotein convertase subtilisin\/kexin type 9 inhibition and aortic stenosis in the FOURIER trial","volume":"5","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584402410120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:04:23Z","timestamp":1778886263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584402410120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":36,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S240584402410120X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34089","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic proxy of lipid-lowering drugs and calcific aortic valve stenosis: A Mendelian randomization study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34089"}}